Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;81(1):374-83.
doi: 10.1128/JVI.01134-06. Epub 2006 Oct 18.

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

Sharookh B Kapadia  1 , Heidi Barth, Thomas Baumert, Jane A McKeating, Francis V Chisari
Affiliations

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

Sharookh B Kapadia et al. J Virol. 2007 Jan.

Abstract

In the past several years, a number of cellular proteins have been identified as candidate entry receptors for hepatitis C virus (HCV) by using surrogate models of HCV infection. Among these, the tetraspanin CD81 and scavenger receptor B type I (SR-BI), both of which localize to specialized plasma membrane domains enriched in cholesterol, have been suggested to be key players in HCV entry. In the current study, we used a recently developed in vitro HCV infection system to demonstrate that both CD81 and SR-BI are required for authentic HCV infection in vitro, that they function cooperatively to initiate HCV infection, and that CD81-mediated HCV entry is, in part, dependent on membrane cholesterol.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
SR-BI is required for JFH-1 infection. Huh-7 cells were incubated with anti-CD81 or anti-SR-BI antibody and inoculated with JFH-1, and infectivity was analyzed by measuring intracellular JFH-1 RNA at 3 days postinfection. (A) Huh-7 cells were infected with JFH-1 in the presence of three dilutions each of anti-CD81 (250, 25, and 10 μg/ml) and anti-SR-BI (1:20, 1:50, and 1:100) antibodies. As controls, Huh-7 cells were incubated with isotype-matched mouse IgG (mIgG) and PI rat serum at 250-μg/ml and 1:50 dilutions, respectively. (B) Huh-7 cells were incubated with concentrations of anti-CD81 antibodies alone (bars with horizontal lines), anti-SR-BI antibodies alone (unfilled bars), or both antibodies (bars with diagonal lines), and intracellular JFH-1 RNA levels were measured 3 days later. Two dilutions each of anti-CD81 (25 and 2.5 μg/ml) and anti-SR-BI (1:50 and 1:100) antibodies were used. To demonstrate cooperativity, Huh-7 cells were incubated with combinations of anti-CD81 and anti-SR-BI antibodies. Cells were incubated with anti-CD81 and anti-SR-BI antibodies (25 μg/ml anti-CD81 plus 1:50 anti-SR-BI and 2.5 μg/ml anti-CD81 plus 1:100 anti-SR-BI). As controls for anti-CD81 and anti-SR-BI antibodies, Huh-7 cells were incubated with equivalent concentrations of isotype-matched mouse IgG and PI rat serum, respectively. HCV RNA copy numbers were normalized to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) copy numbers for all samples. These are representative data (means ± SDs) for three independent experiments. (C) Inhibition of HCVpp entry using antibodies specific to CD81 (25 mg/ml) and SR-BI (1:50) individually or in combination. TU, transducing units. These are representative data (means ± SDs) for three replicates.
FIG. 2.
FIG. 2.
Anti-SR-BI antibodies inhibit JFH-1 NS5A protein expression. Indirect immunofluorescence analysis of NS5A protein expressed in JFH-1-infected Huh-7 cells alone (A) or in the presence of anti-CD81 (25 μg/ml) (D), anti-SR-BI (1:50) (E), or a combination of both anti-CD81 and anti-SR-BI antibodies (F). Huh-7 cells were incubated with equivalent concentrations of isotype-matched mouse IgG (mIgG) (B) and PI rat serum (C) as controls for the anti-CD81 and anti-SR-BI antibodies, respectively. The bars represent 400-μm distances. These are representative data for three independent experiments.
FIG. 3.
FIG. 3.
MβCD treatment of Huh-7 cells decreases CD81 plasma membrane expression. CD81 expression was analyzed in mock-treated Huh-7 cells (A) or in Huh-7 cells after treatment with 10 mM MβCD (B). CD81 expression was also determined in MβCD-treated cells to which exogenous cholesterol was added (C). SR-BI expression was also analyzed in mock-treated (D) and MβCD-treated (E) Huh-7 cells. The bars represent 60-μm distances. These are representative data for at least two independent experiments.
FIG. 4.
FIG. 4.
CD81 cell surface expression decreases after MβCD treatment. Cell surface expression of CD81 (A) and SR-BI (B) was analyzed in mock-treated Huh-7 cells (M), Huh-7 cells that were treated with 10 mM MβCD (MβCD), or MβCD-treated cells which were further incubated with cholesterol (MβCD+C). (C) MFI of CD81 surface expression after mock treatment or treatment with 10 mM MβCD in the presence (MβCD+C) or absence (MβCD) of exogenous cholesterol are plotted. These are representative data for at least two independent experiments.
FIG. 5.
FIG. 5.
Depletion of cholesterol by MβCD decreases JFH-1 infection in Huh-7 cells. Huh-7 cells were untreated or pretreated with 7.5 mM MβCD alone (MβCD) or MβCD plus cholesterol (MβCD + C) prior to infection with JFH-1. (A) Total RNA was harvested 3 days later, and levels of intracellular JFH-1 RNA were quantitated by RT-PCR. Relative HCV levels were measured by normalization to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) copy numbers for each sample. (B) Intracellular cholesterol levels were quantitated in mock-treated Huh-7 cells or cells that were treated with MβCD alone (MβCD) or MβCD plus cholesterol (MβCD + C). (C) Viable cells were quantitated by trypan blue exclusion after MβCD treatment (in the absence or presence of cholesterol) and compared to mock-treated Huh-7 cells.
FIG. 6.
FIG. 6.
Depletion of cholesterol by MβCD does not affect HCV RNA replication. (A) Huh-7 cells stably replicating the JFH-1 SG replicon were treated with 7.5 mM MβCD, and intracellular levels of JFH-1 RNA were measured at 1 and 2 days posttreatment. (B) Intracellular cholesterol levels in Huh-7 cells were quantitated after treatment with MβCD (MβCD) or MβCD plus cholesterol (MβCD+C). (C and D) Huh-7 cells were infected with JFH-1 for 9 days, after which cells were untreated or treated with 7.5 mM MβCD (MβCD) or MβCD plus cholesterol (MβCD+C). Intracellular JFH-1 RNA levels (C) and JFH-1 virus secretion (D) were quantitated before the start of treatment (day 0) and at 2 days posttreatment. These are representative data (means ± SDs) for three independent experiments. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ffu, focus-forming units.
FIG. 7.
FIG. 7.
Depletion of cholesterol by MβCD decreases HCVpp entry in Huh-7 cells. (A) Dose-dependent inhibition of HCVpp infection of Huh-7 cells after treatment with 2.5, 5, and 10 mM MβCD. (B) Huh-7 cells were untreated or treated with 10 mM MβCD (MβCD) or 10 mM MβCD plus cholesterol (MβCD+C) and infected with HCVpp or MLVpp. Relative light units (RLU) for each sample were calculated by normalization to mock-treated Huh-7 cells. These are representative data (means ± standard errors of the means) for two independent experiments.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Agnello, V., G. Abel, M. Elfahal, G. B. Knight, and Q. X. Zhang. 1999. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 96:12766-12771. - PMC - PubMed
    1. Allander, T., X. Forns, S. U. Emerson, R. H. Purcell, and J. Bukh. 2000. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. Virology 277:358-367. - PubMed
    1. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, et al. 1992. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 327:1899-1905. - PubMed
    1. André, P., F. Komurian-Pradel, S. Deforges, M. Perret, J. L. Berland, M. Sodoyer, S. Pol, C. Brechot, G. Paranhos-Baccala, and V. Lotteau. 2002. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76:6919-6928. - PMC - PubMed
    1. Babitt, J., B. Trigatti, A. Rigotti, E. J. Smart, R. G. Anderson, S. Xu, and M. Krieger. 1997. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem. 272:13242-13249. - PubMed

Publication types

MeSH terms